These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24287905)

  • 41. Bromocriptine in the treatment of parkinsonism.
    Parkes JD
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.
    Singaram C; Ashraf W; Gaumnitz EA; Torbey C; Sengupta A; Pfeiffer R; Quigley EM
    Lancet; 1995 Sep; 346(8979):861-4. PubMed ID: 7564669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.
    Yoshimoto Y; Nakaso K; Nakashima K
    FEBS Lett; 2005 Feb; 579(5):1197-202. PubMed ID: 15710413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis.
    Kaushik P; Gorin F; Vali S
    J Comput Neurosci; 2007 Apr; 22(2):147-60. PubMed ID: 17053993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease.
    White RB; Thomas MG
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):340-9. PubMed ID: 22483315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of salsolinol on tyrosine hydroxylase.
    Briggs GD; Nagy GM; Dickson PW
    Neurochem Int; 2013 Dec; 63(8):726-31. PubMed ID: 24083987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease.
    Heo JY; Nam MH; Yoon HH; Kim J; Hwang YJ; Won W; Woo DH; Lee JA; Park HJ; Jo S; Lee MJ; Kim S; Shim JE; Jang DP; Kim KI; Huh SH; Jeong JY; Kowall NW; Lee J; Im H; Park JH; Jang BK; Park KD; Lee HJ; Shin H; Cho IJ; Hwang EM; Kim Y; Kim HY; Oh SJ; Lee SE; Paek SH; Yoon JH; Jin BK; Kweon GR; Shim I; Hwang O; Ryu H; Jeon SR; Lee CJ
    Curr Biol; 2020 Jan; 30(2):276-291.e9. PubMed ID: 31928877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.
    Khakimova GR; Kozina EA; Kucheryanu VG; Ugrumov MV
    Mol Neurobiol; 2017 Jul; 54(5):3618-3632. PubMed ID: 27194433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylase.
    Parveen Z; Nawaz MS; Shakil S; Greig NH; Kamal MA
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):463-8. PubMed ID: 22583429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in research on Parkinsonism.
    Rinne UK
    Acta Neurol Scand Suppl; 1978; 67():77-113. PubMed ID: 31053
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute alcohol exposure increases tyrosine hydroxylase protein expression and dopamine synthesis in zebrafish.
    Tran S; Facciol A; Nowicki M; Chatterjee D; Gerlai R
    Behav Brain Res; 2017 Jan; 317():237-241. PubMed ID: 27666381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.
    Fifel K; Dkhissi-Benyahya O; Cooper HM
    Chronobiol Int; 2013 Jul; 30(6):741-55. PubMed ID: 23758587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours.
    Barbosa P; Hapuarachchi B; Djamshidian A; Strand K; Lees AJ; de Silva R; Holton JL; Warner TT
    Brain; 2019 Nov; 142(11):3580-3591. PubMed ID: 31603207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.
    Kuhn DM; Arthur RE; Thomas DM; Elferink LA
    J Neurochem; 1999 Sep; 73(3):1309-17. PubMed ID: 10461926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical aspects of experimentally induced parkinsonism.
    Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
    [No Abstract]   [Full Text] [Related]  

  • 57. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M
    Ann N Y Acad Sci; 1984; 430():1-5. PubMed ID: 6146282
    [No Abstract]   [Full Text] [Related]  

  • 58. The function of tyrosine hydroxylase in the normal and Parkinsonian brain.
    Tolleson C; Claassen D
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):381-6. PubMed ID: 22483314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
    Pruett BS; Salvatore MF
    Mol Neurobiol; 2013 Jun; 47(3):988-99. PubMed ID: 23321789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.